FDA Brief

Warning letters Food

FDA warning letter to

Perrigo Wisconsin, LLC

High riskIssued Aug 30, 2023Posted Aug 30, 2023HUMAN AND ANIMAL FOOD WEST I COMPLIANCE BRANCH (HAFW1-CB)

FDA found Cronobacter in Perrigo infant formula and facility; company recalled some Gerber Good Start Soothe Pro.

What happened

FDA inspected the Eau Claire, Wisconsin powdered infant formula plant from March 6 through April 26, 2023. FDA found Cronobacter spp. in finished products from three production campaigns and in environmental swabs; some environmental strains matched strains found at the same facility in March 2022. The company recalled impacted Gerber Good Start Soothe Pro batches in March 2023 after FDA review and discussions.

What FDA found

  1. The company did not have process controls for all production stages designed to keep microorganisms out of the infant formula.

    21 C.F.R. § 106.55(a)
  2. Finished infant formula products tested positive for Cronobacter spp. in three production campaigns.

    21 C.F.R. § 106.55(a)
  3. Root cause investigations did not use DNA fingerprinting (whole genome sequencing) or swab surfaces before cleaning to compare bacteria found in product and facility.

    21 C.F.R. § 106.55(a)
  4. FDA environmental swabs found C. sakazakii, and two strains matched strains found at the same facility in March 2022, indicating resident pathogens or places where the bacterium can persist.

    21 C.F.R. § 106.55(a)
  5. The company did not clearly define corrective actions for pathogen detections and did not investigate positive pathogen samples from high-potential product-contact areas.

    21 C.F.R. § 106.55(a)
  6. The company did not show its dry cleaning was sufficient to control microbiological contamination and did not consider missing sanitation breaks in product disposition decisions.

    21 C.F.R. § 106.55(a)

What FDA wants

FDA tells Perrigo to fix gaps in its root cause investigations, evaluate sanitation and hygienic controls when deciding product disposition, and continue looking for places where the bacterium can persist; FDA will check corrective actions at the next inspection. The letter text provided does not state a response deadline.

Who should pay attention

  • infant formula brand owners and distributors
  • contract manufacturers of powdered infant formula
  • quality teams managing environmental monitoring and product disposition

This is a summary. Read the original letter on fda.gov.

Similar letters to other companies

  1. Graceleigh, Inc. dba Sammy’s Milk

    FDA warned Sammy's Milk that it markets goat milk toddler formula as infant formula without required notice and falsely claimed Cronobacter testing.

    High risk
  2. Reckitt/Mead Johnson Nutrition

    FDA warned Reckitt/Mead Johnson over Cronobacter contamination and inadequate process controls at two powdered infant formula plants.

    High risk
  3. ByHeart, Inc.

    FDA warns ByHeart that Cronobacter contamination in infant formula and weak investigations led to release of adulterated powdered formula.

    High risk
  4. Lyons Magnus, LLC

    FDA warned Lyons Magnus about microbial contamination in aseptic low-acid beverages and delayed reporting of contaminated lots.

    High risk